Transaction in Own Shares

PureTech Health PLC
14 December 2023
 

14 December 2023

 

PureTech Health plc

 

Transaction in Own Shares

 

PureTech Health PLC (the "Company") announces that it has purchased the following number of its ordinary shares of one pence each through Jefferies International Limited ("Jefferies"), as part of its Share Buyback Programme, details of which were announced on 9 May 2022.

 

Date of purchase:             

13 December 2023



Number of ordinary shares purchased:

57,399



Highest price paid per share:

144.00p



Lowest price paid per share:

142.40p



Volume weighted average price paid per share:

143.22p

 

PureTech intends to retain the purchased shares in treasury.

Following the above transaction, the Company will have 17,176,348 ordinary shares in treasury and has 272,291,811 ordinary shares in issue (excluding treasury shares). The total number of voting rights in the Company is therefore 272,291,811 which may be used by shareholders in their calculations to determine if they are required to notify their interest in, or a change to their interest in, PureTech Health plc under the FCA's Disclosure Guidance and Transparency Rules.

 

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018) (the Market Abuse Regulation), detailed information about the individual purchases is available below.

 

About PureTech Health

PureTech is a clinical-stage biotherapeutics company dedicated to giving life to new classes of medicine to change the lives of patients with devastating diseases. The Company has created a broad and deep pipeline through its experienced research and development team and its extensive network of scientists, clinicians and industry leaders that is being advanced both internally and through its Founded Entities. PureTech's R&D engine has resulted in the development of 27 therapeutics and therapeutic candidates, including two (Plenity® and EndeavorRx®) that have received both U.S. FDA clearance and European marketing authorization and a third (KarXT) that has been filed for FDA approval. A number of these programs are being advanced by PureTech or its Founded Entities in various indications and stages of clinical development, including registration enabling studies. All of the underlying programs and platforms that resulted in this pipeline of therapeutic candidates were initially identified or discovered and then advanced by the PureTech team through key validation points.

 

For more information, visit www.puretechhealth.com or connect with us on X, formerly known as Twitter, @puretechh.

 

Contact:

PureTech

Investor Relations

IR@puretechhealth.com

Individual Transactions

 

Transaction Date

Transaction Time

Volume

Price (GBp)

Platform

Transaction Reference Number

13/12/2023

09:15:18

681

143

CHIX

00382108679TRLO0.1.1

13/12/2023

09:15:18

681

143

CHIX

00382108680TRLO0.1.1

13/12/2023

09:15:18

1362

143

XLON

00382108681TRLO0.1.1

13/12/2023

09:16:18

29

142.4

BATE

00382108805TRLO0.1.1

13/12/2023

09:16:18

141

142.4

TRQX

00382108808TRLO0.1.1

13/12/2023

09:16:22

521

142.4

BATE

00382108826TRLO0.1.1

13/12/2023

09:16:22

557

142.8

XLON

00382108828TRLO0.1.1

13/12/2023

09:16:22

68

142.8

XLON

00382108829TRLO0.1.1

13/12/2023

09:16:22

54

142.8

XLON

00382108830TRLO0.1.1

13/12/2023

09:16:22

1036

142.8

XLON

00382108831TRLO0.1.1

13/12/2023

09:16:22

121

143

XLON

00382108832TRLO0.1.1

13/12/2023

10:09:56

1098

144

XLON

00382116772TRLO0.1.1

13/12/2023

10:09:56

4557

144

XLON

00382116773TRLO0.1.1

13/12/2023

10:09:57

288

144

AQXE

00382116776TRLO0.1.1

13/12/2023

10:09:57

193

143

CHIX

00382116777TRLO0.1.1

13/12/2023

10:16:50

524

143.4

CHIX

00382117667TRLO0.1.1

13/12/2023

10:19:15

681

143.8

XLON

00382118174TRLO0.1.1

13/12/2023

10:49:03

36

144

AQXE

00382122565TRLO0.1.1

13/12/2023

11:11:51

2724

144

XLON

00382126890TRLO0.1.1

13/12/2023

11:11:56

252

144

AQXE

00382126915TRLO0.1.1

13/12/2023

11:20:31

645

143.4

CHIX

00382128072TRLO0.1.1

13/12/2023

11:25:49

82

143.4

XLON

00382128992TRLO0.1.1

13/12/2023

11:25:49

119

144

XLON

00382128993TRLO0.1.1

13/12/2023

11:25:49

480

144

XLON

00382128994TRLO0.1.1

13/12/2023

11:36:27

225

143

AQXE

00382130223TRLO0.1.1

13/12/2023

11:36:27

288

143

AQXE

00382130224TRLO0.1.1

13/12/2023

11:36:27

63

143

AQXE

00382130225TRLO0.1.1

13/12/2023

11:36:27

488

143

CHIX

00382130226TRLO0.1.1

13/12/2023

11:36:27

354

143

CHIX

00382130228TRLO0.1.1

13/12/2023

11:36:27

624

143.4

XLON

00382130227TRLO0.1.1

13/12/2023

11:36:27

57

144

XLON

00382130229TRLO0.1.1

13/12/2023

11:36:27

211

143

BATE

00382130230TRLO0.1.1

13/12/2023

11:36:27

339

143

BATE

00382130231TRLO0.1.1

13/12/2023

11:36:27

1362

143

XLON

00382130248TRLO0.1.1

13/12/2023

11:49:47

681

142.8

XLON

00382131767TRLO0.1.1

13/12/2023

11:49:47

681

142.8

XLON

00382131768TRLO0.1.1

13/12/2023

12:45:03

225

142.8

BATE

00382139552TRLO0.1.1

13/12/2023

12:45:03

550

142.8

BATE

00382139553TRLO0.1.1

13/12/2023

12:45:03

325

142.8

BATE

00382139554TRLO0.1.1

13/12/2023

12:45:03

520

142.8

CHIX

00382139557TRLO0.1.1

13/12/2023

12:45:03

681

142.8

XLON

00382139561TRLO0.1.1

13/12/2023

12:45:03

681

142.8

XLON

00382139560TRLO0.1.1

13/12/2023

13:16:23

681

142.8

CHIX

00382143970TRLO0.1.1

13/12/2023

13:16:23

1362

142.8

XLON

00382143974TRLO0.1.1

13/12/2023

13:16:26

282

143

TRQX

00382143982TRLO0.1.1

13/12/2023

13:48:23

550

142.8

BATE

00382149138TRLO0.1.1

13/12/2023

13:48:23

681

142.8

CHIX

00382149139TRLO0.1.1

13/12/2023

13:48:23

2043

142.8

XLON

00382149141TRLO0.1.1

13/12/2023

13:59:55

12

143

XLON

00382151334TRLO0.1.1

13/12/2023

13:59:55

83

143

XLON

00382151335TRLO0.1.1

13/12/2023

14:34:50

318

143.2

CHIX

00382162681TRLO0.1.1

13/12/2023

14:45:12

515

143.2

CHIX

00382167967TRLO0.1.1

13/12/2023

15:09:52

355

143.4

CHIX

00382181339TRLO0.1.1

13/12/2023

15:24:30

1773

143.4

CHIX

00382189617TRLO0.1.1

13/12/2023

15:34:32

1092

143.6

CHIX

00382195072TRLO0.1.1

13/12/2023

15:38:02

714

143.4

CHIX

00382196717TRLO0.1.1

13/12/2023

15:38:02

1362

143.4

XLON

00382196719TRLO0.1.1

13/12/2023

15:49:13

576

143.4

AQXE

00382201460TRLO0.1.1

13/12/2023

15:49:13

681

143.4

CHIX

00382201462TRLO0.1.1

13/12/2023

15:49:13

2367

143.4

XLON

00382201464TRLO0.1.1

13/12/2023

15:49:13

141

143.4

TRQX

00382201465TRLO0.1.1

13/12/2023

15:51:32

1254

143.2

XLON

00382202575TRLO0.1.1

13/12/2023

15:56:23

550

143.2

BATE

00382204904TRLO0.1.1

13/12/2023

15:56:23

681

143.2

CHIX

00382204905TRLO0.1.1

13/12/2023

15:56:23

789

143.2

XLON

00382204908TRLO0.1.1

13/12/2023

15:56:23

550

143.2

BATE

00382204907TRLO0.1.1

13/12/2023

15:56:23

1935

143.2

XLON

00382204909TRLO0.1.1

13/12/2023

15:57:23

576

143.4

AQXE

00382205525TRLO0.1.1

13/12/2023

16:00:58

681

143

XLON

00382207181TRLO0.1.1

13/12/2023

16:00:58

2724

143

XLON

00382207182TRLO0.1.1

13/12/2023

16:00:58

564

143.4

TRQX

00382207189TRLO0.1.1

13/12/2023

16:04:47

6

143.4

TRQX

00382208712TRLO0.1.1

13/12/2023

16:05:21

4

143.4

AQXE

00382209157TRLO0.1.1

13/12/2023

16:05:49

6

143.4

TRQX

00382209490TRLO0.1.1

13/12/2023

16:06:11

4

143.4

AQXE

00382209753TRLO0.1.1

13/12/2023

16:06:55

6

143.4

TRQX

00382210112TRLO0.1.1

13/12/2023

16:07:10

4

143.4

AQXE

00382210217TRLO0.1.1

13/12/2023

16:07:29

4

143.4

AQXE

00382210313TRLO0.1.1

13/12/2023

16:07:30

6

143.4

TRQX

00382210315TRLO0.1.1

13/12/2023

16:08:01

6

143.4

TRQX

00382210630TRLO0.1.1

13/12/2023

16:08:29

4

143.4

AQXE

00382210866TRLO0.1.1

13/12/2023

16:08:33

6

143.4

TRQX

00382210876TRLO0.1.1

13/12/2023

16:09:17

4

143.4

AQXE

00382211233TRLO0.1.1

13/12/2023

16:09:35

4

143.4

AQXE

00382211300TRLO0.1.1

13/12/2023

16:09:46

166

143.4

AQXE

00382211367TRLO0.1.1

13/12/2023

16:14:17

6

143.4

TRQX

00382212943TRLO0.1.1

13/12/2023

16:19:47

4

143.4

AQXE

00382215832TRLO0.1.1

13/12/2023

16:21:47

209

142.8

CHIX

00382216878TRLO0.1.1

13/12/2023

16:21:47

266

142.8

AQXE

00382216880TRLO0.1.1

13/12/2023

16:21:47

116

142.8

AQXE

00382216879TRLO0.1.1

13/12/2023

16:21:47

472

142.8

CHIX

00382216881TRLO0.1.1

13/12/2023

16:21:47

163

142.8

CHIX

00382216883TRLO0.1.1

13/12/2023

16:21:47

158

142.8

CHIX

00382216882TRLO0.1.1

13/12/2023

16:21:47

550

142.8

BATE

00382216885TRLO0.1.1

13/12/2023

16:21:47

1362

142.8

XLON

00382216892TRLO0.1.1

13/12/2023

16:27:41

111

143

XLON

00382220707TRLO0.1.1

13/12/2023

16:28:31

550

142.8

BATE

00382221110TRLO0.1.1

13/12/2023

16:29:32

31

142.8

XLON

00382221694TRLO0.1.1

13/12/2023

16:29:32

1331

142.8

XLON

00382221695TRLO0.1.1

13/12/2023

16:29:49

80

143.4

TRQX

00382222076TRLO0.1.1

13/12/2023

16:29:49

160

143.4

TRQX

00382222078TRLO0.1.1

13/12/2023

16:29:50

15

142.8

BATE

00382222092TRLO0.1.1

13/12/2023

16:29:56

408

142.8

BATE

00382222196TRLO0.1.1

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings